Matches in SemOpenAlex for { <https://semopenalex.org/work/W2426492540> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2426492540 endingPage "70" @default.
- W2426492540 startingPage "759" @default.
- W2426492540 abstract "The next decade will face an increase in the number of patients affected by end-stage renal disease. In line with the growing incidence of type 2 diabetes, hypertension and old age in the general population, we can expect a dramatic increase of uremic patients needing a substitutive treatment of renal function. On the basis of the current trends, we expect an exponential growth of cardiovascular complications in both dialysis and transplant populations. Progress in the treatment of end-stage renal disease will aim at the prevention of cardiovascular complications, that remain the leading cause of morbidity and mortality in uremic patients. Preventive interventions for cardiovascular complications should focus on traditional risk factors, such as hypertension, dyslipidemia and obesity, diabetes mellitus, smoking, as well as on the non traditional risk factors inherent in the uremic state, such as anemia, hyperphosphoremia, hyperhomocysteinemia, inflammation and malnutrition. Recent and future innovations in peritoneal dialysis solutions include a larger use of icodextrin, a glucose polymer able to enhance ultrafiltration while inducing less glycation and caloric absorption, and perhaps improving blood pressure control. The gene therapy directed to the mesothelial cells should bring about improvements in nutrition, cardiovascular comorbidity, and dialysis adequacy. Patients submitted to increased hemodialysis time or to the implementation of a night or daily hemodialysis program have shown better blood pressure control, cardiovascular stability, tolerability and perhaps reduced mortality. Modifications of dialysis schedules clearly indicate another road to future improvements in renal replacement therapy. In the field of kidney transplantation, much improvement has already been achieved regarding the prevention of acute rejection, and the new therapeutic strategies are aimed at reducing the incidence of the adverse reactions of immunosuppressive drugs, as well as of the chronic allograft nephropathy. Induction of transplantation tolerance remains the most attractive target, which now seems closer than before because many of the mechanisms involved in the tolerance induction have been better elucidated." @default.
- W2426492540 created "2016-06-24" @default.
- W2426492540 creator A5028834600 @default.
- W2426492540 creator A5050470878 @default.
- W2426492540 creator A5051338388 @default.
- W2426492540 date "2006-12-01" @default.
- W2426492540 modified "2023-09-23" @default.
- W2426492540 title "[Perspectives on treatment of the renal failure]." @default.
- W2426492540 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17252735" @default.
- W2426492540 hasPublicationYear "2006" @default.
- W2426492540 type Work @default.
- W2426492540 sameAs 2426492540 @default.
- W2426492540 citedByCount "0" @default.
- W2426492540 crossrefType "journal-article" @default.
- W2426492540 hasAuthorship W2426492540A5028834600 @default.
- W2426492540 hasAuthorship W2426492540A5050470878 @default.
- W2426492540 hasAuthorship W2426492540A5051338388 @default.
- W2426492540 hasConcept C126322002 @default.
- W2426492540 hasConcept C134018914 @default.
- W2426492540 hasConcept C177713679 @default.
- W2426492540 hasConcept C2778063415 @default.
- W2426492540 hasConcept C2778096610 @default.
- W2426492540 hasConcept C2778653478 @default.
- W2426492540 hasConcept C2779056158 @default.
- W2426492540 hasConcept C2779134260 @default.
- W2426492540 hasConcept C2779541074 @default.
- W2426492540 hasConcept C2779978075 @default.
- W2426492540 hasConcept C2908647359 @default.
- W2426492540 hasConcept C2911091166 @default.
- W2426492540 hasConcept C555293320 @default.
- W2426492540 hasConcept C71924100 @default.
- W2426492540 hasConcept C84393581 @default.
- W2426492540 hasConcept C99454951 @default.
- W2426492540 hasConceptScore W2426492540C126322002 @default.
- W2426492540 hasConceptScore W2426492540C134018914 @default.
- W2426492540 hasConceptScore W2426492540C177713679 @default.
- W2426492540 hasConceptScore W2426492540C2778063415 @default.
- W2426492540 hasConceptScore W2426492540C2778096610 @default.
- W2426492540 hasConceptScore W2426492540C2778653478 @default.
- W2426492540 hasConceptScore W2426492540C2779056158 @default.
- W2426492540 hasConceptScore W2426492540C2779134260 @default.
- W2426492540 hasConceptScore W2426492540C2779541074 @default.
- W2426492540 hasConceptScore W2426492540C2779978075 @default.
- W2426492540 hasConceptScore W2426492540C2908647359 @default.
- W2426492540 hasConceptScore W2426492540C2911091166 @default.
- W2426492540 hasConceptScore W2426492540C555293320 @default.
- W2426492540 hasConceptScore W2426492540C71924100 @default.
- W2426492540 hasConceptScore W2426492540C84393581 @default.
- W2426492540 hasConceptScore W2426492540C99454951 @default.
- W2426492540 hasIssue "12" @default.
- W2426492540 hasLocation W24264925401 @default.
- W2426492540 hasOpenAccess W2426492540 @default.
- W2426492540 hasPrimaryLocation W24264925401 @default.
- W2426492540 hasRelatedWork W1438698095 @default.
- W2426492540 hasRelatedWork W1535481232 @default.
- W2426492540 hasRelatedWork W1536778544 @default.
- W2426492540 hasRelatedWork W2046659774 @default.
- W2426492540 hasRelatedWork W2181600260 @default.
- W2426492540 hasRelatedWork W2330201142 @default.
- W2426492540 hasRelatedWork W2605949870 @default.
- W2426492540 hasRelatedWork W2951665603 @default.
- W2426492540 hasRelatedWork W2965268372 @default.
- W2426492540 hasRelatedWork W4229046768 @default.
- W2426492540 hasVolume "97" @default.
- W2426492540 isParatext "false" @default.
- W2426492540 isRetracted "false" @default.
- W2426492540 magId "2426492540" @default.
- W2426492540 workType "article" @default.